Converge
No summary available yet.
Converge is a solid mid-tier Boston fund that punches above its weight in AI/B2B software. They're not flashy but they're competent — think of them as the reliable Honda Civic of VC funds. Scholnick and Beim actually know enterprise software inside and out, unlike many AI tourist investors. They move fast on decisions and don't waste your time with endless partner meetings. The downside? Limited capital for follow-ons and smaller network compared to tier-1 funds, so you might need to graduate to bigger names for later rounds.
- —Best for: Technical B2B founders who want fast decisions and real operational help
- —Watch out for: Limited follow-on capital for later rounds
- —Known for: No-nonsense approach and deep enterprise software expertise
Converge invests in early-stage B2B software companies, particularly those applying AI and machine learning to transform traditional industries. They focus on technical founders building defensible moats through proprietary data or algorithms.
Seed to Series A B2B software, heavy emphasis on AI/ML applications in logistics, supply chain, fintech, and healthcare. Typical check sizes $500K-$2M.
Former Trinity Ventures partner with 20+ years in enterprise software. Known for hands-on operational support and strong network in Boston tech scene. Founders appreciate his direct communication style.
Ex-Venrock partner who moved to Converge to lead AI investments. Deep technical background and pattern recognition in machine learning companies. Reputation for being data-driven in due diligence.
Have a specific question about Converge?
Ask Bernie →